Mandate

Vinge represents ADB BVBA in connection with the acquisition of Safegate

February 26, 2016

Vinge, together with Willkie Farr & Gallagher, represents ADB BVBA, a portfolio company to the French private equity fund PAI Partners, in its acquisition of Safegate from Fairford. Together they will form the new ADB Safegate group.

Safegate is a leading airfield solutions business providing aircraft docking guidance systems, gate management systems, airfield lighting solutions and air traffic control systems to more than 1,300 airports in 130 countries. Safegate is headquartered in Malmö, Sweden, has more than 300 employees worldwide and generated revenue of SEK 1.3 billion in 2015. The ADB Group comprises ADB Airfield Solutions, LUCEBIT and ERNI AGL, three world-leading airfield technology companies specializing in end-to-end, integrated and sustainable solutions for visual guidance. The ADB Group has a worldwide presence and experience spanning 69 years in airfield lighting. More than 2000 airports in 175 countries have chosen ADB as their preferred partner for airside operations.

Vinge’s team primarily consisted of Jonas Bergström, Maria Dahlin, Ulrich Ziche, Samra Baytar, Manne Bergström, Linn Adelwald, Adam Sandberg, Maria Schultzberg, Jasmin Draszka-Ali, Carl Sander, Isabell Nielsen and Lova Unge.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026